Moderna's Covid vaccine for teens awaits OK as regulators review heart inflammation risk

Moderna applied for emergency approval of its Covid vaccine for 12- to 17-year-olds in June, but the FDA said its review wouldn't be completed before January.

from Health and Science https://ift.tt/QOp8TUC
https://ift.tt/F9uXfGo
https://ift.tt/W0HUJxR